15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Lifevantage Corporation, 1 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $6.00 to $11.00, a moderate spread. The average target of $8.50 sits 32% above the current $6.42. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.08 next quarter toward $0.39 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Lifevantage Corporation.
As of Sep, 1 of 2 firms rate LFVN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
LFVN EPS & revenue forecast
EPS · NEXT QUARTER
$0.08
Range $0.06 – $0.11 · 3 analysts · -47% YoY
Next period, 3 analysts expect Lifevantage Corporation to earn $0.08 a share (range $0.06 – $0.11), versus $0.15 a year earlier. Full-year consensus is $0.32, growing to $0.39 the year after.
REVENUE · NEXT QUARTER
$41.7M
Range $39.7M – $44.0M · 3 analysts · -15% YoY
Revenue is expected to reach $41.7M (range $39.7M – $44.0M), -14.9% year-over-year. Full-year consensus is $165.5M, rising to $167.7M next year.
Top analysts covering Lifevantage Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LFVN.
#1
Ryan Meyers
Lake Street
Hold
$6.00-6.5% to target
Coverage
—
+ Follow
#2
BO
Brooks O'Neil
Lake Street
Hold
$5.00-22.1% to target
Coverage
—
+ Follow
#3
IZ
Ilya Zubkov
Freedom Broker
Buy
$11.00+71.3% to target
Coverage
—
+ Follow
#4
AF
Alex Fuhrman
Craig-Hallum
Buy
$35.00+445.2% to target
Coverage
—
+ Follow
LFVN stock forecast FAQ
What is LFVN's average 12-month price target?+
The 2 analysts with a live target average $8.50 for Lifevantage Corporation over the next 12 months, ranging from a $11.00 high to a $6.00 low.
Is LFVN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for LFVN?+
The Street-high target is $11.00 (Freedom Broker), and the Street-low is $6.00 (Lake Street). The average of all 2 active targets is $8.50.
How many Wall Street analysts cover LFVN?+
2 analysts have an active rating on Lifevantage Corporation, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering LFVN?+
Among analysts who currently cover LFVN, Ryan Meyers of Lake Street has the strongest overall Quantellect track record. Their current call is Hold with a $6.00 target.
What is Lifevantage Corporation's projected EPS for next quarter?+
The consensus estimate is $0.08 per share (range $0.06 – $0.11) across 3 analysts. Full-year EPS is projected at $0.32, rising to $0.39 the following year.
How much revenue is Lifevantage Corporation expected to report next quarter?+
Consensus revenue is $41.7M (range $39.7M – $44.0M). Full-year revenue is projected at $165.5M, growing to $167.7M next year.
Have analysts been upgrading or downgrading LFVN lately?+
As of Sep, 1 of 2 firms rate LFVN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LFVN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
